Your browser doesn't support javascript.
Indian contribution toward biomedical research and development in COVID-19: A systematic review.
Kaur, Hardeep; Kaur, Manpreet; Bhattacharyya, Anusuya; Prajapat, Manisha; Thota, Prasad; Sarma, Phulen; Kumar, Subodh; Kaur, Gurjeet; Sharma, Saurabh; Prakash, Ajay; Saifuddin, P K; Medhi, Bikash.
  • Kaur H; Department of Pediatric, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Kaur M; Department of Nursing, AIIMS, Rishikesh, Uttarakhand, India.
  • Bhattacharyya A; Department of Ophthalmology, GMCH-32, Chandigarh, India.
  • Prajapat M; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Thota P; Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India.
  • Sarma P; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Kumar S; UIPS, Punjab University, India.
  • Kaur G; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sharma S; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Prakash A; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Saifuddin PK; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Medhi B; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Pharmacol ; 53(1): 63-72, 2021.
Article in English | MEDLINE | ID: covidwho-1225882
ABSTRACT
COVID-19 pandemic led to an unprecedented collaborative effort among industry, academia, regulatory bodies, and governments with huge financial investments. Scientists and researchers from India also left no stone unturned to find therapeutic and preventive measures against COVID-19. Indian pharmaceutical companies are one of the leading manufacturers of vaccine in the world, are utilizing its capacity to its maximum, and are one among the forerunners in vaccine research against COVID-19 across the globe. In this systematic review, the information regarding contribution of Indian scientists toward COVID-19 research has been gathered from various news articles across Google platform apart from searching PubMed, WHO site, COVID-19 vaccine tracker, CTRI, clinicaltrials.gov, and websites of pharmaceutical companies. The article summarizes and highlights the various therapeutic and vaccine candidates, diagnostic kits, treatment agents, and technology being developed and tested by Indian researcher community against COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Biomedical Research / Drug Discovery / Drug Development / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Diagnostic study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Vaccines Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: Indian J Pharmacol Year: 2021 Document Type: Article Affiliation country: Ijp.ijp_168_21

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Biomedical Research / Drug Discovery / Drug Development / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Diagnostic study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Vaccines Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: Indian J Pharmacol Year: 2021 Document Type: Article Affiliation country: Ijp.ijp_168_21